The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 02, 2021

Filed:

May. 14, 2020
Applicant:

Emods Technology, L.l.c., Georgetown, TX (US);

Inventor:

Paul Dabney, Georgetown, TX (US);

Assignee:

EMODs Technology, L.L.C., Georgetown, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01D 21/00 (2006.01); B01D 21/01 (2006.01); B01D 21/26 (2006.01); C02F 1/02 (2006.01); C02F 1/32 (2006.01); C02F 1/38 (2006.01); C02F 1/66 (2006.01); C02F 1/72 (2006.01); C02F 1/78 (2006.01); C02F 9/00 (2006.01); C02F 1/76 (2006.01); C02F 103/00 (2006.01); C02F 101/30 (2006.01);
U.S. Cl.
CPC ...
C02F 9/00 (2013.01); B01D 21/0012 (2013.01); B01D 21/01 (2013.01); B01D 21/262 (2013.01); C02F 1/02 (2013.01); C02F 1/32 (2013.01); C02F 1/38 (2013.01); C02F 1/722 (2013.01); C02F 1/76 (2013.01); C02F 1/78 (2013.01); B01D 21/009 (2013.01); C02F 1/66 (2013.01); C02F 2101/30 (2013.01); C02F 2103/003 (2013.01); C02F 2103/006 (2013.01); C02F 2303/04 (2013.01); C02F 2305/02 (2013.01);
Abstract

Described herein is a method for differentially lysing a liquid sample or target material using an Augmented Oxidizing Agent (AOA), which includes a quantity of Electronically Modified Oxygen Derivatives (EMODs). The method reduces or eliminates total dissolved solids (TDS), total suspended solids (TSS), microbial concentration, biofilms and other content in the liquid target material known or suspected to contain animal fluids, blood and blood cells and suspected or known to contain eukaryotic cells, microbial cells, bacteria, viruses, spores, fungi, prions, organic matter, minerals, proteins or associated structures. The TDS and TSS can be lowered or eliminated as desired. This action is directly proportional to the quantity of EMODs in the AOS applied to the liquid target material.


Find Patent Forward Citations

Loading…